Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gentian Diagnostics ASA Share Issue/Capital Change 2021

Dec 10, 2021

3604_rns_2021-12-10_74d73e08-b693-46d0-b23a-137b87ee72ee.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Share capital increase registered - Correction*

Share capital increase registered - Correction*

Moss, 9 December 2021

Reference is made to the stock exchange notice from Gentian Diagnostics ASA (the

"Company") on 29 November 2021 regarding a share issue in connection with an

employee share purchase program (ESPP), by issuance of *10,461 new shares in the

Company at a subscription price of NOK 54.49 per new share. The share capital

increase pertaining to the ESPP is now registered with the Norwegian Register of

Business Enterprises. The Company's new registered share capital is NOK

1,542,235.0 divided on 15,422,350 shares, each with a nominal value of NOK 0.10.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Njaal Kind

CFO, Gentian Diagnostics

E-mail: [email protected]

Cell Phone: +47 919 06 525